Three-drug combo tested to stop early breast cancer from coming back
NCT ID NCT02654119
Summary
This study tested a combination of three drugs given after surgery for early-stage HER2-positive breast cancer. The goal was to see if this treatment could help prevent the cancer from returning and to understand its side effects. It involved 20 patients who received the drug regimen and then were monitored for two years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE IIA BREAST CANCER AJCC V6 AND V7 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Faith Regional Health Services Carson Cancer Center
Norfolk, Nebraska, 68701, United States
-
Nebraska Medicine-Village Pointe
Omaha, Nebraska, 68118, United States
-
University of Nebraska Medical Center
Omaha, Nebraska, 68198, United States
Conditions
Explore the condition pages connected to this study.